RWP
CRNX icon

RWA Wealth Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History

RWA Wealth Partners’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$337K Buy
9,271
+2,425
+35% +$108K ﹤0.01% 520
2025
Q4 		$319K Buy
6,846
+1,150
+20% +$51.2K ﹤0.01% 511
2025
Q3 		$237K Buy
+5,696
New +$182K ﹤0.01% 572
2025
Q1 		– Sell
-5,696
Closed -$291K – 549
2024
Q4 		$291K Hold
5,696
– – ﹤0.01% 493
2024
Q3 		$291K Hold
5,696
– – ﹤0.01% 482
2024
Q2 		$255K Hold
5,696
– – ﹤0.01% 486
2024
Q1 		$267K Hold
5,696
– – ﹤0.01% 478
2023
Q4 		$203K Buy
+5,696
New +$175K ﹤0.01% 507

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return